Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 5:20 pm Purchase | 2026-06-30 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Perceptive Advisors LLC | 6,627,501 7.300% | 195,758 (+3.04%) | Filing History |
| 2026-08-14 4:52 pm Unchanged | 2026-06-30 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Caligan Partners LP | 7,967,207 8.800% | 0 (Unchanged) | Filing History |
| 2026-08-14 4:07 pm Purchase | 2026-06-30 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Commodore Capital LP | 8,948,170 9.900% | 4,425,193 (+97.84%) | Filing History |
| 2026-08-14 4:07 pm Sale | 2026-06-30 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Vivo Opportunity Fund Holdings, L.P. | 22,637,108 9.990% | -3,293,892 (-12.70%) | Filing History |
| 2026-08-14 11:04 am Sale | 2026-06-30 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Woodline Partners LP | 5,455,355 6.800% | -1,670,526 (-23.44%) | Filing History |
| 2026-08-14 06:08 am Purchase | 2026-06-30 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | BALYASNY ASSET MANAGEMENT L.P. | 7,225,439 9.450% | 2,135,500 (+41.96%) | Filing History |
| 2026-08-12 12:08 pm Purchase | 2026-06-30 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Adage Capital Management, L.P. | 6,405,553 8.380% | 6,405,553 (New Position) | Filing History |
| 2026-08-10 4:27 pm Purchase | 2026-08-06 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | RA Capital Management, L.P. | 9,609,852 9.900% | 2,298,627 (+31.44%) | Filing History |
| 2026-05-15 4:00 pm Purchase | 2026-03-31 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Perceptive Advisors LLC | 6,431,743 8.400% | 2,959,882 (+85.25%) | Filing History |
| 2026-05-15 11:17 am Purchase | 2026-03-31 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Caligan Partners LP | 7,967,207 10.400% | 7,967,207 (New Position) | Filing History |
| 2026-05-15 06:28 am Purchase | 2026-03-31 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | BALYASNY ASSET MANAGEMENT L.P. | 5,089,939 9.990% | 5,089,939 (New Position) | Filing History |
| 2026-05-01 4:57 pm Purchase | 2026-04-24 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Millennium Management LLC | 3,432,153 5.100% | 3,432,153 (New Position) | Filing History |
| 2026-03-23 4:25 pm Purchase | 2026-03-19 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | RA Capital Management, L.P. | 7,311,225 9.900% | 2,144,801 (+41.51%) | Filing History |
| 2026-03-11 4:43 pm Purchase | 2026-03-09 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | RA Capital Management, L.P. | 5,166,424 9.900% | 764,924 (+17.38%) | Filing History |
| 2026-02-17 4:23 pm Sale | 2025-12-31 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | BIOTECHNOLOGY VALUE FUND L P | 4,761,906 9.100% | -405,712 (-7.85%) | Filing History |
| 2026-02-17 08:47 am Purchase | 2025-12-31 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | RTW Investments, LP | 1,587,302 3.200% | 562,967 (+54.96%) | Filing History |
| 2026-01-22 4:34 pm Purchase | 2026-01-14 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Perceptive Advisors LLC | 3,471,861 7.300% | 3,471,861 (New Position) | Filing History |
| 2025-11-14 4:24 pm Purchase | 2025-09-30 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | BIOTECHNOLOGY VALUE FUND L P | 5,167,618 9.990% | 4,249,790 (+463.03%) | Filing History |
| 2025-11-14 4:18 pm Purchase | 2025-09-30 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Woodline Partners LP | 7,125,881 9.900% | 7,125,881 (New Position) | Filing History |
| 2025-10-03 4:30 pm Purchase | 2025-09-29 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Vivo Opportunity Fund Holdings, L.P. | 25,931,000 9.990% | 25,931,000 (New Position) | Filing History |